Skip to main content
Clinical Trials/ACTRN12623001347651
ACTRN12623001347651
Not yet recruiting
Phase 4

Determine whether analgesia for patients undergoing minimally invasive major abdominal surgery using Intrathecal Morphine with local anaesthetic affects quality of recovery. The AIM Study.

Alfred Health0 sites280 target enrollmentDecember 20, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Anaesthesiology
Sponsor
Alfred Health
Enrollment
280
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 20, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Greater than or equal to 18 years old
  • Patients scheduled for elective major laparoscopic, lap\-assisted or robotic abdominal surgery, and
  • Major surgery is that with a planned operative time of over 2 hours

Exclusion Criteria

  • \< 18 years old
  • Patient declines enrolment or inability to consent
  • Contraindication to intrathecal morphine
  • Contraindication to a neuraxial injection, including; injection site concerns, coagulopathy (including administration of anticoagulant), or untreated sepsis
  • Cognitive impairment or language proficiency leading to inability to complete QoR\-15 questionnaire or understand the pain scores
  • Chronic pain, including baseline opioid use prior to hospital admission

Outcomes

Primary Outcomes

Not specified

Similar Trials